Charles River Laboratories (CRL) Tops Q3 EPS by 53c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $326.29 --0%
Financial Fact:
Discontinued operations (in dollars per share): 0.01
Today's EPS Names:
ROX, KEEL, SENEA, More
Financial Fact:
Discontinued operations (in dollars per share): 0.01
Today's EPS Names:
ROX, KEEL, SENEA, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q3 EPS of $2.33, $0.53 better than the analyst estimate of $1.80. Revenue for the quarter came in at $743.3 million versus the consensus estimate of $716.36 million.
GUIDANCE:
Charles River Laboratories sees FY2020 EPS of $7.75-$7.85, versus the consensus of $7.26.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MACOM Technology Solutions (MTSI) Tops Q4 EPS by 9c ; Offers Guidance
- Icahn Enterprises L.P. (INGR) Tops Q3 EPS by 12c ; Offers Guidance
- Intensity Therapeutics, Inc. (INTS) Misses Q3 EPS by 13c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
